Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (101-110 of 347) with videos related to

Pageof 35
Sort By:
International Journal of Cancer|September 16, 2016
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancerMelanie Maierthaler, Axel Benner, Michael Hoffmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2017
Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis PatientsKatharina Lisenko, Patrick Wuchter, Marion Hansberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutationsStefan Fröhling, Richard F Schlenk, Ina Stolze, et al.
Breast Cancer Research and Treatment|September 28, 2006
The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutationAnna Jakubowska, Jacek Gronwald, Bohdan Górski, et al.
Transplantation and Cellular Therapy|March 20, 2024
Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported CauseElisa Sala, Adela M Neagoie, Jan Lewerenz, et al.
Breast Cancer Research : BCR|November 8, 2019
Pre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivorsAudrey Y Jung, Sabine Behrens, Martina Schmidt, et al.
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
Cancer Medicine|December 29, 2017
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained responseNicola Lehners, Natalia Becker, Axel Benner, et al.
BMC Molecular Biology|June 26, 2008
Off-target effects of siRNA specific for GFPCordula Tschuch, Angela Schulz, Armin Pscherer, et al.
Trials|April 24, 2026
PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trialRouvier Al-Monajjed, Peter Albers, Matthias Boschheidgen, et al.
Pageof 35

Showing results (101-110 of 347) with videos related to

Sort By:
Pageof 35
International Journal of Cancer|September 16, 2016
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancerMelanie Maierthaler, Axel Benner, Michael Hoffmeister, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2017
Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis PatientsKatharina Lisenko, Patrick Wuchter, Marion Hansberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutationsStefan Fröhling, Richard F Schlenk, Ina Stolze, et al.
Breast Cancer Research and Treatment|September 28, 2006
The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutationAnna Jakubowska, Jacek Gronwald, Bohdan Górski, et al.
Transplantation and Cellular Therapy|March 20, 2024
Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported CauseElisa Sala, Adela M Neagoie, Jan Lewerenz, et al.
Breast Cancer Research : BCR|November 8, 2019
Pre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivorsAudrey Y Jung, Sabine Behrens, Martina Schmidt, et al.
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.
Cancer Medicine|December 29, 2017
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained responseNicola Lehners, Natalia Becker, Axel Benner, et al.
BMC Molecular Biology|June 26, 2008
Off-target effects of siRNA specific for GFPCordula Tschuch, Angela Schulz, Armin Pscherer, et al.
Trials|April 24, 2026
PRIMA: randomized prospective multicenter non-inferiority study for primary diagnosis of clinically significant PRostate cancer by PSA and MR IMAging-study protocol for a randomized diagnostic accuracy trialRouvier Al-Monajjed, Peter Albers, Matthias Boschheidgen, et al.
Pageof 35